Improved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12

Neuroblastoma immunotherapy using cytokine-modified tumour cells has been tested in clinical trials. However, because of the complex nature of antitumour immune responses, a number of therapies may be required for complete tumour eradication and generation of systemic immunity. We report here the im...

Descripción completa

Detalles Bibliográficos
Autores principales: Siapati, K E, Barker, S, Kinnon, C, Michalski, A, Anderson, R, Brickell, P, Thrasher, A J, Hart, S L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377114/
https://www.ncbi.nlm.nih.gov/pubmed/12771934
http://dx.doi.org/10.1038/sj.bjc.6600928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377114/
https://www.ncbi.nlm.nih.gov/pubmed/12771934
http://dx.doi.org/10.1038/sj.bjc.6600928

Ejemplares similares